Drug Infusion System Market Research Report – Forecast to 2023

Global Drug Infusion System Market Research Report, by Product Type (Elastomeric Infusion System, Disposable Infusion System), by Application (Oncology/Chemotherapy), Mode of Administration (Intravenous), End-User (Hospitals) - Global Forecast Till 2023

ID: MRFR/MED/4748-HCR | February 2021 | Region: Global | 100 pages

Market Scenario


The drug infusion systems are medical devices that allow infusion of drugs like antibiotics, chemotherapy drugs, insulin, painkillers and others in a controlled manner.


The increase in the prevalence of chronic diseases like cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis drives the market growth. According to the World Health Organization 2018, 70% of deaths occur due to non-communicable diseases like diabetes, heart disease, stroke, chronic lung disease and heart disease, stroke, cancer worldwide. Also, the rising geriatric population, adoption of technologically advanced devices and rising healthcare spending provide favorable backgrounds for the market to grow. Also, due to their easy to use, portability, ergonomic design, and visual monitoring features favor the potential growth of the market.


However, factors such as the high cost of drug infusion system, shortage of skilled labor and stringent government rules and regulations for product approval are expected to restrict the market growth during the forecast period.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


Extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and commercial study of the global drug infusion system market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, international organization of chemical manufacturers, some paid databases, and many others.


Segmentation


The global Drug infusion system market is segmented on the basis of product type, mode of administration, application, and end-user. The drug infusion system market, by product type, is sub-segmented into elastomeric infusion system, disposable infusion system, syringe infusion system, peristaltic pump, multi-channel pump, Patient-Controlled Analgesia (PCA) pump, insulin pump, and implantable infusion system. On the basis of application, the market is categorized into oncology/chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and others. The mode of administration is further sub-segmented into intravenous, subcutaneous, arterial, epidural, and others. On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, and others.


On the basis of region, the global drug infusion system market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.


The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Global Drug infusion system Market, by Key Players



  • Medtronic

  • arcomed AG

  • Braun Melsungen AG

  • Baxter

  • Becton Dickinson and Company

  • Debiotech S.A.

  • Fresenius SE & Co. KGaA

  • Halyard Health, Inc

  • ICU Medical Inc

  • IRadimed Corporation

  • Insulet Corporation

  • Terumo Corporation

  • Smiths Group plc

  • Tandem Diabetes Care

  • MOOG INC.

  • Others


Regional Market Summary


Global Drug infusion system Market Share (%), by Region, 2017


 Drug infusion system Market Share


Sources: World Health Organization, Heart Disease and Stroke Statistics 2018, Organization for Economic Co-operation and Development, Asian Diabetes Prevention Initiative


The drug infusion system market is dominated by North America owing to the rising chronic diseases region. According to the Heart Disease and Stroke Statistics 2018, 836,546 deaths in the US were due to cardiovascular disease. Such a high incidence rate of cardiovascular diseases drives the market growth in this region


It is estimated that Europe stood second in the global Drug infusion system market. Increasing prevalence of chronic disease, rising health care expenditure and health care activities are driving the growth of this market in Europe. As per the Organization for Economic Co-operation and Development (OECD) in 2016, 550,000 working‑age people died due to chronic disease in European Union countries.  Such a high prevalence of chronic disease is expected to boost the market in this region.


Asia Pacific was projected to be the fastest growing region for the global Drug infusion system market.


Drug infusion systems are frequently used for delivering insulin into patient’s body. Growing prevalence of diabetes influences the market in this region. According to the Asian Diabetes Prevention Initiative, 60% of the world’s diabetic population lives in Asia. This propels the growth of the market in this region.


The Middle East and Africa holds the least share in the global Drug infusion system market due to the presence of stringent government policies and poor economies. However, increasing investment by private market players in this region can boost the market growth. 


Market Segmentation and Key Market Players


Global Drug infusion system Market, by Product Type



  • Elastomeric infusion system

  • Disposable infusion system

  • Syringe infusion system

  • Peristaltic pump

  • Multi-channel pump

  • Patient-controlled analgesia (PCA) pump

  • Insulin pump

  • Implantable infusion system


Global Drug infusion system Market, by Application



  • Oncology/Chemotherapy

  • Diabetes

  • Analgesia

  • Nutrition

  • Hematology

  • Pediatrics

  • Others


Global Drug infusion system Market, by Mode of administration



  • Intravenous

  • Subcutaneous

  • Arterial

  • Epidural

  • Others


Global Drug infusion system Market, by End-user



  • Hospitals

  • Ambulatory Surgical Centers

  • Diagnostic centers

  • Others


Global Drug infusion system Market, by Region



  • The Americas

  • Europe

  • Asia Pacific

  • The Middle East & Africa


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers



Frequently Asked Questions (FAQ) :


Drug infusion system market has a high cost of the procedure, strict government rules, lack of product approval, and lack of skilled labor as major deterrents.

The system has segments like disposable infusion system, elastomeric infusion system, multi-channel pump, syringe infusion system, peristaltic pump, insulin pump, Patient-Controlled Analgesia (PCA) pump, and implantable infusion system.

The applications are diabetes, oncology/chemotherapy, nutrition, hematology, analgesia, pediatrics, and others.

The segments are intravenous, subcutaneous, arterial, epidural, and others.

The end users are diagnostic centers, ambulatory surgical centers, hospitals, and others.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Drug infusion system Market, by Product Type

6.1 Introduction

6.2 Elastomeric infusion system

6.3 Disposable infusion system

6.4 Syringe infusion system

6.5 Peristaltic pump

6.6 Multi-channel pump

6.7 Patient-controlled analgesia (PCA) pump

6.8 Insulin pump

6.9 Implantable infusion system

Chapter 7. Global Drug infusion system Market, by Application

7.1 Introduction

7.2 Oncology/Chemotherapy
7.3 Diabetes

7.4 Analgesia

7.5 Nutrition

7.6 Hematology

7.7 Pediatrics

7.8 Others

Chapter 8. Global Drug infusion system Market, by Mode of administration

8.1 Introduction

8.2 Intravenous

8.3 Subcutaneous

8.4 Arterial

8.5 Epidural

8.6 Others

Chapter 10. Global Drug infusion system Market, by End-User

10.1 Introduction

10.2 Hospitals

10.3 Ambulatory Surgical Centers

10.4 Diagnostic centers

10.5 Others

Chapter 11. Global Drug infusion system Market, by Region

11.1 Introduction

11.2 America

11.2.1 North America

11.2.1.1 US

11.2.1.2 Canada

11.2.2 South America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 Italy

11.3.1.4 Spain

11.3.1.5 UK

11.3.1.6 Rest of Western Europe

11.3.2 Eastern Europe

11.4 Asia-Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 Republic of Korea

11.4.6 Rest of Asia-Pacific

11.5 The Middle East & Africa

11.5.1 United Arab Emirates

11.5.2 Saudi Arabia

11.5.3 Oman

11.5.4 Kuwait

11.5.5 Qatar

11.5.6 Rest of the Middle East & Africa

Chapter 12. Company Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

12.3.1 Key Developments

Chapter 13 Company Profiles

13.1 MEDTRONIC

13.1.1 Company Overview

13.1.2 Type Overview

13.1.3 Financials

13.2.4 Key Developments

13.1.5 SWOT Analysis

13.2 Arcomed AG

13.2.1 Company Overview

13.2.2 Type Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.3 B. Braun Melsungen AG

13.3.1 Company Overview

13.3.2 Type Overview

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.4 Baxter

13.4.1 Company Overview

13.4.2 Type/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.5 Debiotech S.A.

13.5.1 Company Overview

13.5.2 Type Overview

13.5.3 Financial overview

13.5.4 Key Developments

13.5.5 SWOT Analysis

13.6 Fresenius SE & Co. KGaA

13.6.1 Company Overview

13.6.2 Type Overview

13.6.3 Financial Overview

13.6.4 Key Developments

13.6.5 SWOT Analysis

13.7 BECTON DICKINSON AND COMPANY

13.7.1 Overview

13.7.2 Type Overview

13.7.3 Financials

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.8 Halyard Health, Inc

13.8.1 Overview

13.8.2 Type Overview

13.8.3 Financials

13.8.4 Key Developments

13.8.5 SWOT Analysis

13.9 ICU Medical Inc

13.9.1 Overview

13.9.2 Type Overview

13.9.3 Financials

13.9.4 Key Developments

13.9.5 SWOT Analysis

13.10 IRadimed Corporation

13.10.1 Overview

13.10.2 Type Overview

13.10.3 Financials

13.10.4 Key Developments

13.10.5 SWOT Analysis

13.11 Insulet Corporation

13.11.1 Overview

13.11.2 Type Overview

13.11.3 Financials

13.11.4 Key Developments

13.11.5 SWOT Analysis

13.12 Terumo Corporation

13.12.1 Overview

13.12.2 Type Overview

13.12.3 Financials

13.12.4 Key Developments

13.12.5 SWOT Analysis

13.13 Smiths Group plc

13.13.1 Overview

13.13.2 Type Overview

13.13.3 Financials

13.13.4 Key Developments

13.13.5 SWOT Analysis

13.14 Tandem Diabetes care

13.14.1 Overview

13.14.2 Type Overview

13.14.3 Financials

13.14.4 Key Developments

13.14.5 SWOT Analysis

13.15 MOOG INC

13.15.1 Overview

13.15.2 Type Overview

13.15.3 Financials

13.15.4 Key Developments

13.15.5 SWOT Analysis

13.16 Others

Chapter 14 Appendix

LIST OF TABLES

Table 1 Drug infusion system Market Industry Synopsis, 2018–2023

Table 2 Global Drug infusion system Market Estimates & Forecast, 2018–2023, (USD Million)

Table 3 Global Drug infusion system Market, by Region, 2018–2023, (USD Million)

Table 4 Global Drug infusion system Market, by Product Type, 2018–2023, (USD Million)

Table 6 Global Drug infusion system Market, by Mode of Administration, 2018–2023, (USD Million)

Table 7 Global Drug infusion system Market, by Application, 2018–2023, (USD Million)

Table 8 Global Drug infusion system Market, by End-User, 2018–2023, (USD Million

Table 9 North America Drug infusion system Market, by Product Type, 2018–2023, (USD Million)

Table 11 North America Drug infusion system Market, by Mode of Administration, 2018–2023, (USD Million)

Table 12 North America Drug infusion system Market, by Application, 2018–2023, (USD Million)

Table 13 North America Drug infusion system Market, by End-User, 2018–2023, (USD Million)

Table 14 US Drug infusion system Market, by Product Type, 2018–2023, (USD Million)

Table 16 US Drug infusion system Market, by Mode of Administration, 2018–2023, (USD Million)

Table 17 US Drug infusion system Market, by Application, 2018–2023, (USD Million)

Table 18 US Drug infusion system Market, by End-User, 2018–2023, (USD Million)

Table 19 Canada Drug infusion system Market, by Product Type, 2018–2023, (USD Million)

Table 21 Canada Drug infusion system Market, by Mode of Administration, 2018–2023, (USD Million)

Table 22 Canada Drug infusion system Market, by Application, 2018–2023, (USD Million)

Table 23 Canada Drug infusion system Market, by End-User, 2018–2023, (USD Million)

Table 24 South America Drug infusion system Market, by Product Type, 2018–2023, (USD Million)

Table 26 South America Drug infusion system Market, by Mode of Administration, 2018–2023, (USD Million)

Table 27 South America Drug infusion system Market, by Application, 2018–2023, (USD Million)

Table 28 South America Drug infusion system Market, by End-User, 2018–2023, (USD Million)

Table 31 Europe Drug infusion system Market, Mode of Administration, 2018–2023, (USD Million)

Table 32 Europe Drug infusion system Market, by Application, 2018–2023, (USD Million)

Table 33 Europe Drug infusion system Market, by End-User, 2018–2023, (USD Million)

Table 34 Western Europe Drug infusion system Market, by Product Type, 2018–2023, (USD Million)

Table 36 Western Europe Drug infusion system Market, by Mode of Administration, 2018–2023, (USD Million)
Table 37 Western Europe Drug infusion system Market, by Application, 2018–2023, (USD Million)

Table 38 Western Europe Drug infusion system Market, by End-User, 2018–2023, (USD Million)

Table 39 Eastern Europe Drug infusion system Market, by Product Type, 2018–2023, (USD Million)

Table 41 Eastern Europe Drug infusion system Market, by Mode of Administration, 2018–2023, (USD Million)

Table 42 Eastern Europe Drug infusion system Market, by Application, 2018–2023, (USD Million)

Table 43 Eastern Europe Drug infusion system Market, by End-User, 2018–2023, (USD Million)

Table 44 Asia-Pacific Drug infusion system Market, by Product Type, 2018–2023, (USD Million)

Table 46 Asia-Pacific Drug infusion system Market, by Mode of Administration, 2018–2023, (USD Million)

Table 47 Asia-Pacific Drug infusion system Market, by Application, 2018–2023, (USD Million)

Table 48 Asia-Pacific Drug infusion system Market, by End-User, 2018–2023, (USD Million)

Table 49 The Middle East & Africa Drug infusion system Market, by Product Type, 2018–2023, (USD Million)

Table 51 The Middle East & Africa Drug infusion system Market, by Mode of Administration, 2018–2023, (USD Million)
Table 52 The Middle East & Africa Drug infusion system Market, by Application, 2018–2023, (USD Million)

Table 53 The Middle East & Africa Drug infusion system Market, by End-User, 2018–2023, (USD Million)
LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Drug infusion system Market

Figure 3 Market Dynamics for Global Drug infusion system Market

Figure 4 Global Drug infusion system Market Share, by Product Type 2017

Figure 5 Global Drug infusion system Market Share, by Application 2017

Figure 5 Global Drug infusion system Market Share, by Mode of administration 2017

Figure 6 Global Drug infusion system Market Share, by End-User, 2017

Figure 7 Global Drug infusion system Market Share, by Region, 2017

Figure 8 North America Drug infusion system Market Share, by Country, 2017

Figure 9 Europe Drug infusion system Market Share, by Country, 2017

Figure 10 Asia-Pacific Drug infusion system Market Share, by Country, 2017

Figure 11 Middle East & Africa Drug infusion system Market Share, by Country, 2017

Figure 12 Global Drug infusion system Market: Company Share Analysis, 2017 (%)

Figure 13 MEDTRONIC: Key Financials

Figure 14 MEDTRONIC: Segmental Revenue

Figure 15 MEDTRONIC: Geographical Revenue

Figure 16 Arcomed AG: Key Financials

Figure 17 Arcomed AG: Segmental Revenue

Figure 18 Arcomed AG: Geographical Revenue

Figure 19 B. Braun Melsungen AG: Key Financials

Figure 20 B. Braun Melsungen AG: Segmental Revenue

Figure 21 B. Braun Melsungen AG: Geographical Revenue

Figure 22 Baxter: Key Financials

Figure 23 Baxter: Segmental Revenue

Figure 24 Baxter: Geographical Revenue

Figure 25 Fresenius SE & Co. KGaA: Key Financials

Figure 26 Fresenius SE & Co. KGaA: Segmental Revenue

Figure 27 Fresenius SE & Co. KGaA: Geographical Revenue

Figure 28 Debiotech S.A.: Key Financials

Figure 29 Debiotech S.A.: Segmental Revenue

Figure 30 Debiotech S.A.: Geographical Revenue

Figure 31 BECTON DICKINSON AND COMPANY: Key Financials

Figure 32 BECTON DICKINSON AND COMPANY: Segmental Revenue

Figure 33 BECTON DICKINSON AND COMPANY: Geographical Revenue

Figure 34 Halyard Health, Inc: Key Financials

Figure 35 Halyard Health, Inc: Segmental Revenue

Figure 36 Halyard Health, Inc: Geographical Revenue

Figure 37 ICU Medical Inc: Key Financials

Figure 38 ICU Medical Inc: Segmental Revenue

Figure 39 ICU Medical Inc: Geographical Revenue

Figure 40 IRadimed Corporation: Key Financials

Figure 41 IRadimed Corporation: Segmental Revenue

Figure 42 IRadimed Corporation: Geographical Revenue

Figure 40 Insulet Corporation: Key Financials

Figure 41 Insulet Corporation: Segmental Revenue

Figure 42 Insulet Corporation: Geographical Revenue

Figure 43 MOOG INC: Key Financials

Figure 44 MOOG INC: Segmental Revenue

Figure 45 MOOG INC: Geographical Revenue

Figure 46 Terumo Corporation: Key Financials

Figure 47 Terumo Corporation: Segmental Revenue

Figure 48 Terumo Corporation: Geographical Revenue

Figure 49 Smiths Group plc: Key Financials

Figure 50 Smiths Group plc: Segmental Revenue

Figure 51 Smiths Group plc: Geographical Revenue

Figure 52 Tandem Diabetes care: Key Financials

Figure 53 Tandem Diabetes care: Segmental Revenue

Figure 54 Tandem Diabetes care: Geographical Revenue